Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol plus intramuscular hyoscine butylbromide versus misoprostol plus placebo for cervical ripening at term
PACTR202605690422756Phase 3Not yet recruiting
- Sponsor
- NINABAI NAPOLEON OFURUMA
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in pregnancy comparing Misoprostol + hyoscine butylbromide with Misoprostol + placebo (2 arms). Primary endpoint: Duration of cervical ripening. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
misoprostolhyoscine butylbromide
03
Conditions
pregnancy
Beyond the preview
Go deeper on PACTR202605690422756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202605690422756.